BioXpress Therapeutics SA is a premier provider of high-quality biosimilar biologic APIs for unmet need indications such as cancer, inflammation and autoimmunity. We have made a commitment to be your partner of choice for the full development of your biosimilar biologic API. BioXpress Therapeutics is focused on developing the highest quality product under strict European Medicines Agency (EMA) guidelines. We bring together the world’s top biologic development, manufacturing and regulatory experts dedicated to your project.
Location: Switzerland
Employees: 1-10
Phone: +41 22 884 86 53
Founded date: 2010
Investors 2
| Date | Name | Website |
| - | Fongit See... | fongitseed... |
| - | VentureLab | venturelab... |
Mentions in press and media 1
| Date | Title | Description |
| 19.11.2012 | BioXpress Therapeutics and AET to Co-Develop Biosimilar with high revenue potential | AET BioTech and BioXpress will be jointly responsible for the development, registration, and manufacture of the biosimilar, which is based on BioXpress technology. The development strategy devised and implemented by the partners incorporate... |